Evidence map›Paper›PMID 32723398›Full record

ArticleJournal of nanobiotechnology2020

Stem cell membrane-coated isotretinoin for acne treatment.

Shiyi Wang, Rihua Jiang, Tianqi Meng, Fuqiang Zhang, Jing Li, Yongri Jin, JeungHoon Lee, Mingji Zhu, Jinlan Jiang

Erratum issuedAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Shiyi WangDepartment of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Rihua JiangDepartment of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Tianqi MengDepartment of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Fuqiang ZhangScientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Jing LiScientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Yongri JinCollege of Chemistry, Jilin University, Changchun, Jilin, China.
JeungHoon LeeDepartment of Dermatology, School of Medicine, Chungnam National University, Daejeon, Republic of Korea.
Mingji ZhuDepartment of Dermatology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. zmj@jlu.edu.cn.
Jinlan JiangScientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. jiangjinlan@jlu.edu.cn.

Funding

Department of Science and Technology of Jilin Province 20170414056GHYouth Program of National Natural Science Foundation of China 51703077
6 · The paper itself

Abstract

backgroundTopical isotretinoin is commonly used to treat acne. However, topical isotretinoin has side effects and can hardly permeate through the stratum corneum, the most important skin barrier. Therefore, this study aimed to demonstrate the efficacy of nanoparticles as stable carriers with great curative effects, low side effects, and strong transdermal ability.

resultsIn a rabbit model of hyperkeratinization, STCM-ATRA-NPs showed significant therapeutic efficacy. By contrast, negative therapeutic efficacy was observed in a golden hamster model of hyper sebum production. Scanning electron microscopy and Fourier transform infrared spectral analyses showed that nanoparticles could penetrate the stratum corneum. Western blotting demonstrated that the nanoparticles could enhance the transdermal efficacy of isotretinoin by reducing the effect of keratin and tight junction proteins. Further, nanoparticles enhanced endocytosis, thereby promoting drug penetration and absorption into the skin.

conclusionSTCM-ATRA-NPs were demonstrated to control isotretinoin release, reducing its side effects, and efficiently permeating through the skin by reducing the effect of keratin and tight junction proteins and enhancing endocytosis.

Indexed as

Acne VulgarisCell MembraneDermatologic AgentsIsotretinoinAdministration, CutaneousAnimalsDisease Models, AnimalDrug CarriersHumansHuman Umbilical Vein Endothelial CellsMaleMesocricetusNanoparticlesRabbitsSkinSkin AbsorptionDermatologic AgentsDrug CarriersIsotretinoinAcneIsotretinoinNanoparticlesStem cellTransdermal

Identifiers

PMID32723398
PMCPMC7390190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.